Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Registry Hub
Peer-Reviewed Evidence
HomeDrug RegistryCompareBEEPEN VK vs AMOXICILLIN
Comparative Pharmacology

BEEPEN VK vs AMOXICILLIN Comparison

Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.

Clinical EssentialsPharmacokineticsSpecial PopulationsSafety & MonitoringPregnancy & Lactation
Differential Analysis

BEEPEN-VK vs AMOXICILLIN

Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.

View BEEPEN-VK Monograph View AMOXICILLIN Monograph
Clinical Insights
BEEPEN-VK
Penicillin Antibiotic
Category C
AMOXICILLIN
Penicillin Antibiotic
Category A/B
TL;DR — Key Differences
  • Half-life: BEEPEN-VK has a half-life of Terminal elimination half-life is 0.7-1.4 hours in patients with normal renal function; prolonged to 3-20 hours in severe renal impairment (Cr Cl <10 m L/min).; AMOXICILLIN has Terminal elimination half-life: 1-1.5 hours in normal renal function. Prolonged to 7-20 hours in end-stage renal disease..
  • No direct drug-drug interaction has been documented between BEEPEN-VK and AMOXICILLIN.
  • Pregnancy: BEEPEN-VK is rated Category C; AMOXICILLIN is rated Category A/B.

Last clinically reviewed: June 2026 · OpiCalc Medical Review Team

Clinical Essentials

BEEPEN-VK
AMOXICILLIN
Mechanism of Action
BEEPEN-VK

Penicillin V potassium is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). This disrupts the cross-linking of peptidoglycan chains, leading to cell lysis and death. It is bactericidal against susceptible organisms.

AMOXICILLIN

Amoxicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity, and activating autolytic enzymes.

Indications
BEEPEN-VK

Streptococcal infections (pharyngitis, scarlet fever),Pneumococcal infections (pneumonia, otitis media),Staphylococcal infections (skin and soft tissue),Prophylaxis of rheumatic fever,Prophylaxis of pneumococcal infection in asplenic patients,Periodontal infections (off-label),Lyme disease (early, off-label)

AMOXICILLIN

Upper respiratory tract infections (e.g., otitis media, sinusitis, pharyngitis/tonsillitis),Lower respiratory tract infections (e.g., community-acquired pneumonia, acute exacerbation of chronic bronchitis),Genitourinary tract infections (e.g., cystitis, urethritis),Skin and skin structure infections,Helicobacter pylori eradication (in combination with clarithromycin and a proton pump inhibitor),Lyme disease (early localized),Prophylaxis of infective endocarditis (for dental procedures in high-risk patients),Off-label: Anthrax (post-exposure prophylaxis), uncomplicated gonorrhea

Standard Dosing
BEEPEN-VK

250-500 mg orally every 6 hours for mild to moderate infections; 500 mg orally every 6 hours for severe infections; maximum 4 g/day.

AMOXICILLIN

250-500 mg orally every 8 hours or 500-875 mg orally every 12 hours; for severe infections, up to 1 g orally every 8 hours.

Direct Interaction
BEEPEN-VK
No Direct Interaction
AMOXICILLIN
No Direct Interaction

Pharmacokinetics

BEEPEN-VK
AMOXICILLIN
Half-Life
BEEPEN-VK

Terminal elimination half-life is 0.7-1.4 hours in patients with normal renal function; prolonged to 3-20 hours in severe renal impairment (Cr Cl <10 m L/min).

AMOXICILLIN

Terminal elimination half-life: 1-1.5 hours in normal renal function. Prolonged to 7-20 hours in end-stage renal disease.

Metabolism
BEEPEN-VK

Penicillin V is primarily metabolized by hydrolysis to penicilloic acid, mainly in the liver. It is excreted largely unchanged in urine via renal tubular secretion.

Special Populations

BEEPEN-VK
AMOXICILLIN
Renal Adjustments
BEEPEN-VK

Cr Cl >50 m L/min: no adjustment; Cr Cl 10-50 m L/min: 250-500 mg every 6-8 hours; Cr Cl <10 m L/min: 250-500 mg every 12-24 hours; hemodialysis: 250-500 mg every 24 hours, with an additional dose after dialysis.

AMOXICILLIN

Cr Cl 30-50 m L/min: 250-500 mg every 8-12 hours. Cr Cl 10-29 m L/min: 250-500 mg every 12 hours. Cr Cl <10 m L/min: 250-500 mg every 24 hours. Hemodialysis: 250-500 mg every 24 hours, supplemented during and after dialysis.

Hepatic Adjustments
BEEPEN-VK

Safety & Monitoring

BEEPEN-VK
AMOXICILLIN
Black Box Warnings
BEEPEN-VK
FDA Black Box Warning

No FDA boxed warning exists for penicillin V potassium.

AMOXICILLIN

Pregnancy & Lactation

BEEPEN-VK
AMOXICILLIN
Teratogenic Risk
BEEPEN-VK

Penicillin V (BEEPEN-VK) is classified as FDA Pregnancy Category B. Animal reproduction studies have not demonstrated a risk to the fetus, and there are no adequate and well-controlled studies in pregnant women. However, penicillin V is generally considered safe in all trimesters when used at recommended doses. No teratogenic effects have been consistently reported in humans.

AMOXICILLIN

FDA Pregnancy Category B. No evidence of teratogenicity in animal studies. First trimester: no increased risk of major malformations observed in large cohort studies. Second and third trimesters: use only if clearly needed; no known fetal harm, but caution due to maternal physiological changes.

Clinical Insights

BEEPEN-VK
AMOXICILLIN
Clinical Pearls
BEEPEN-VK

BEEPEN-VK (penicillin V potassium) is acid-stable and can be taken with or without food, but absorption is slightly better on an empty stomach. For streptococcal pharyngitis, continue therapy for 10 days to prevent rheumatic fever. In renal impairment, dose adjustment may be necessary for high doses; no adjustment needed for typical oral doses. Monitor for hypersensitivity reactions, including anaphylaxis, especially in patients with history of penicillin allergy. Use with caution in patients with severe renal impairment or seizure disorders.

AMOXICILLIN

For streptococcal pharyngitis, amoxicillin 50 mg/kg once daily (max 1 g) is as effective as multiple daily doses and improves adherence. In penicillin-allergic patients, the cross-reactivity risk with cephalosporins is low; a cephalosporin can be used if no history of immediate-type hypersensitivity. Amoxicillin is not effective against penicillinase-producing staphylococci or most Gram-negative organisms due to beta-lactamase production. Monitor for rash in patients with infectious mononucleosis (ampicillin rash occurs more frequently, but amoxicillin also has increased risk). Dose adjustment needed for creatinine clearance <30 m L/min.

Safety Verification

Known Interactions

BEEPEN-VK Risks

No interactions on record

AMOXICILLIN Risks3
Phenytoin + Amoxicillin
moderate

"Phenytoin, a potent inducer of cytochrome P450 (CYP) enzymes, particularly CYP3A4 and CYP2C9, increases the metabolism of amoxicillin, a beta-lactam antibiotic. This interaction can lead to reduced plasma concentrations of amoxicillin, potentially compromising its bactericidal efficacy and increasing the risk of therapeutic failure, especially in severe infections such as endocarditis or meningitis."

Amoxicillin + Kanamycin
moderate

"Amoxicillin, a beta-lactam antibiotic, can reduce the serum concentration of Kanamycin, an aminoglycoside, when co-administered. This interaction is believed to occur due to physicochemical inactivation in vitro or reduced gastrointestinal absorption, potentially leading to subtherapeutic kanamycin levels and increased risk of therapeutic failure. Clinically, this may compromise efficacy in treating serious Gram-negative infections, particularly in patients with renal impairment or altered gut motility."

Amoxicillin + Acemetacin
moderate

"Amoxicillin may decrease the excretion rate of Acemetacin which could result in a higher serum level."

Clinical Q&A

Frequently Asked Questions

Common clinical questions about BEEPEN-VK vs AMOXICILLIN, answered by our medical review team.

1. What is the main difference between BEEPEN-VK and AMOXICILLIN?

BEEPEN-VK is a Penicillin Antibiotic that works by Penicillin V potassium is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). This disrupts the cross-linking of peptidoglycan chains, leading to cell lysis and death. It is bactericidal against susceptible organisms.. AMOXICILLIN is a Penicillin Antibiotic that works by Amoxicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity, and activating autolytic enzymes.. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.

2. Which is stronger: BEEPEN-VK or AMOXICILLIN?

Potency comparisons between BEEPEN-VK and AMOXICILLIN depend on the specific clinical indication. These are both Penicillin Antibiotic agents and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.

3. What is the standard dosing for BEEPEN-VK vs AMOXICILLIN?

The standard adult dose of BEEPEN-VK is: 250-500 mg orally every 6 hours for mild to moderate infections; 500 mg orally every 6 hours for severe infections; maximum 4 g/day.. The standard adult dose of AMOXICILLIN is: 250-500 mg orally every 8 hours or 500-875 mg orally every 12 hours; for severe infections, up to 1 g orally every 8 hours.. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.

4. Can you take BEEPEN-VK and AMOXICILLIN together?

No direct drug-drug interaction has been formally documented between BEEPEN-VK and AMOXICILLIN in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.

5. Are BEEPEN-VK and AMOXICILLIN safe during pregnancy?

The maternal-fetal safety profiles differ. BEEPEN-VK is classified as Category C. Penicillin V (BEEPEN-VK) is classified as FDA Pregnancy Category B. Animal reproduction studies have not demonstrated a risk to the fetus, and there are no adequate and well-contro. AMOXICILLIN is classified as Category A/B. FDA Pregnancy Category B. No evidence of teratogenicity in animal studies. First trimester: no increased risk of major malformations observed in large cohort studies. Second and th. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.

AMOXICILLIN

Amoxicillin is primarily metabolized by hydrolysis to penicilloic acid (inactive). It is not extensively metabolized by the liver; about 60% of an oral dose is excreted unchanged in urine.

Excretion
BEEPEN-VK

Primarily renal (70-80% as unchanged drug), with minor biliary/fecal excretion. Renal clearance is via tubular secretion and glomerular filtration.

AMOXICILLIN

Renal: 60-80% unchanged via glomerular filtration and tubular secretion. Biliary: up to 20% excreted in bile. Fecal: minimal.

Protein Binding
BEEPEN-VK

75-89% bound, primarily to albumin and to a lesser extent to alpha-1-acid glycoprotein.

AMOXICILLIN

17-20% bound to serum albumin.

VD (L/kg)
BEEPEN-VK

0.3-0.4 L/kg; represents distribution into total body water and moderate tissue penetration.

AMOXICILLIN

0.3-0.4 L/kg. Distributes well into most body fluids and tissues, including pleural, peritoneal, and synovial fluids; limited CNS penetration unless meninges inflamed.

Bioavailability
BEEPEN-VK

Oral: 30-60% (variable due to acid lability and first-pass metabolism); Intramuscular: 100%.

AMOXICILLIN

Oral: 74-92% (absorption is not food-dependent). IM: approximately 100%.

No specific guidelines; use with caution in severe hepatic impairment; no dose adjustment recommended for mild to moderate Child-Pugh A or B; Child-Pugh C: consider dose reduction and monitor for adverse effects.

AMOXICILLIN

No dose adjustment required for mild to moderate hepatic impairment. Severe hepatic impairment (Child-Pugh class C): use with caution; specific dosing guidelines not established.

Pediatric Dosing
BEEPEN-VK

Children >1 month: 25-50 mg/kg/day divided every 6 hours; severe infections: up to 100 mg/kg/day divided every 6 hours; maximum 4 g/day.

AMOXICILLIN

Children >3 months: 20-40 mg/kg/day divided every 8 hours for mild to moderate infections; 40-90 mg/kg/day divided every 8-12 hours for severe infections. Maximum 3 g/day.

Geriatric Dosing
BEEPEN-VK

No specific dose adjustment; monitor renal function and adjust based on Cr Cl; elderly may be more susceptible to adverse effects (e.g., Clostridium difficile infection).

AMOXICILLIN

No specific dose adjustment; monitor renal function and adjust based on Cr Cl. Caution with concurrent nephrotoxic agents.

FDA Black Box Warning

No FDA black box warning.

Warnings/Precautions
BEEPEN-VK
  • Hypersensitivity reactions (anaphylaxis, rash, urticaria)
  • Cross-allergenicity with cephalosporins
  • Superinfection with prolonged use
  • Clostridium difficile-associated diarrhea
  • Use in renal impairment may require dose adjustment
AMOXICILLIN
  • Hypersensitivity reactions including anaphylaxis have been reported; contraindicated in patients with known penicillin allergy.
  • Clostridium difficile-associated diarrhea (CDAD) may occur and must be considered in patients presenting with diarrhea after antibiotic use.
  • Serious skin reactions (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis) can occur; discontinue if rash or other allergic signs appear.
  • Use caution in patients with renal impairment; dosage adjustment may be necessary.
  • Prolonged use may result in superinfection with non-susceptible organisms.
Contraindications
BEEPEN-VK
  • Hypersensitivity to penicillins or any component
  • Previous serious allergic reaction (e.g., anaphylaxis) to beta-lactams
AMOXICILLIN
  • History of hypersensitivity reaction to any penicillin or beta-lactam antibiotic.
  • Infectious mononucleosis (increases risk of maculopapular rash).
  • Phenylketonuria (some formulations contain aspartame).
Adverse Reactions
BEEPEN-VK
Data Pending
AMOXICILLIN
Data Pending
Food Interactions
BEEPEN-VK

Take penicillin V potassium on an empty stomach, at least 1 hour before or 2 hours after meals. Avoid acidic beverages (e.g., fruit juices, cola) as they can degrade the drug. No significant interactions with other foods; however, calcium-rich foods (dairy) are not contraindicated but may slightly delay absorption. Avoid alcohol during therapy as it may increase side effects like nausea.

AMOXICILLIN

No significant food interactions. Absorption is not affected by food; may be taken with meals to reduce gastrointestinal upset. Avoid concurrent alcohol consumption as it may increase risk of side effects like nausea and vomiting.

Lactation Summary
BEEPEN-VK

Penicillin V is excreted into breast milk in low concentrations (M/P ratio approximately 0.2-0.3). It is generally considered compatible with breastfeeding due to minimal risk of adverse effects in the infant. However, potential for alteration of infant gut flora or allergic sensitization exists; observe infant for diarrhea, rash, or candidiasis.

AMOXICILLIN

Amoxicillin is excreted into breast milk in small amounts (M/P ratio approximately 0.014-0.015). Considered compatible with breastfeeding; potential for diarrhea or allergic sensitization in infant, but generally safe.

Pregnancy Dosing
BEEPEN-VK

No dosage adjustment is typically required during pregnancy. However, pregnancy-induced increases in renal clearance may theoretically reduce penicillin V levels; standard dosing remains effective for most infections. Severe infections may require dose adjustment based on clinical response and susceptibility.

AMOXICILLIN

No dose adjustment required for amoxicillin in pregnancy; however, increased renal clearance and expanded plasma volume may lower serum concentrations. For severe infections, consider standard dosing with monitoring of clinical response.

Maternal Safety Status
BEEPEN-VK
Category C
AMOXICILLIN
Category A/B
Patient Counseling
BEEPEN-VK

Take this medication exactly as prescribed, even if you feel better.,Complete the full course of therapy to prevent resistance or recurrence.,Take on an empty stomach (1 hour before or 2 hours after meals) for best absorption.,Do not take with fruit juices or acidic beverages as they may reduce effectiveness.,Notify your doctor if you develop rash, itching, swelling, or difficulty breathing.,Store at room temperature away from moisture and heat; do not refrigerate.,Discard any unused antibiotic after finishing course; do not save for later use.,If you miss a dose, take it as soon as possible unless it is almost time for the next dose; do not double the dose.,Inform your doctor if you are pregnant, breastfeeding, or have kidney disease.

AMOXICILLIN

Take exactly as prescribed; complete the full course even if you feel better.,Can be taken with or without food; if stomach upset occurs, take with a meal.,Swallow capsules whole; do not crush or chew; oral suspension shake well before each dose.,Skip missed dose if almost time for next; do not double dose.,Seek immediate medical help for signs of allergic reaction: hives, difficulty breathing, swelling of face/lips/tongue.,May cause diarrhea; contact doctor if watery or bloody stools.,Inform doctor if you are pregnant, planning to become pregnant, or breastfeeding.,Avoid large amounts of grapefruit juice as it may affect absorption (limited clinical significance).